Shots: Abbott and Sanofi team up to develop tools integrating their blood sugar tracking and insulin delivery technologies to help diabetes patients in managing their conditions The non-exclusive agreement will […]readmore
Tags : Collaborated
Shots: The companies jointly enter into P-I trial evaluating the clinical benefits, combining immune stimulator, Immuntep’s eftilagimod alpha (“efti” or “IMP321”), with Merck and Pfizer’s avelumab. Alliances will jointly develop […]readmore
Shots: Mylan to get exclusive commercialization rights of the product in >100 countries, including Africa, Asia, the Middle East, the Commonwealth of Independent States (CIS) and Latin America. Mylan plans […]readmore